Holen Sie sich die Stockscreener-App
5.14
37.09%
-3.03
Schlusskurs vom Vortag:
$8.17
Offen:
$5.88
24-Stunden-Volumen:
1.23M
Relative Volume:
1.49
Marktkapitalisierung:
$3.46M
Einnahmen:
$49,300
Nettoeinkommen (Verlust:
$-6.27M
KGV:
-0.5655
EPS:
-9.09
Netto-Cashflow:
$-5.38M
1W Leistung:
+3.21%
1M Leistung:
-15.81%
6M Leistung:
-29.78%
1J Leistung:
+37.55%
1-Tages-Spanne:
$5.05
$5.96
1-Wochen-Bereich:
$4.95
$9.36
52-Wochen-Spanne:
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
Firmenname
Aclarion Inc
Sektor
Branche
Telefon
833 275 2266
Adresse
8181 ARISTA PLACE, BROOMFIELD
Vergleichen Sie ACON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
5.15 | 5.49M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
240.91 | 39.64B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
67.48 | 12.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.66 | 8.23B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.18 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.97 | 7.05B | 11.99B | 24.18M | 234.31M | 0.2956 |
Aclarion Inc Aktie (ACON) Neueste Nachrichten
Aclarion Announces $10.4 Million Registered Direct Offering - TipRanks
Aclarion Signs Multiple Material Agreements - TradingView — Track All Markets
Why Tilray Brands Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Aclarion, Inc., (ACON) stock: surges 39% as Nociscan adoption accelerates into 2026 - parameter.io
Aclarion Stock Climbs 50% After Strong 2025 Results And 2026 Outlook - Nasdaq
Aclarion Inc.: Analyzing the Sudden Surge - StocksToTrade
Is Aclarion Inc. Equity Warrant stock a safe haven assetPortfolio Risk Summary & Fast Moving Market Watchlists - ulpravda.ru
Will Aclarion Inc. stock reach all time highs in 2025Insider Buying & Entry Point Confirmation Signals - ulpravda.ru
Is Aclarion Inc. Equity Warrant stock overvalued by current metricsJuly 2025 Breakouts & Safe Entry Trade Signal Reports - ulpravda.ru
Aclarion Provides 2025 Update and 2026 Corporate Outlook - The Globe and Mail
Why Aclarion Inc. stock appeals to dividend seekers2025 Institutional Moves & Consistent Growth Equity Picks - ulpravda.ru
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
ACON Stock Pops 45% Pre-Market Today: What’s Driving The Move? - Asianet Newsable
Aclarion stock soars on 114% jump in Q4 Nociscan scan volumes By Investing.com - Investing.com South Africa
Aclarion stock soars on 114% jump in Q4 Nociscan scan volumes - Investing.com India
Why Is Aclarion Stock Skyrocketing Thursday?Aclarion (NASDAQ:ACON) - Benzinga
Why Is Aclarion Stock (ACON) Up Today? - TipRanks
Morning Market Movers: ACON, ASPC, IMRX, NVVE See Big Swings - RTTNews
Aclarion's 2025 Nociscan Scan Volumes Hit Record High, Shares Surge 45% - Nasdaq
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Aclarion Provides 2025 Update and 2026 Corporate Outlook - GlobeNewswire Inc.
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data - Ortho Spine News
Why Aclarion Inc. stock is seen as undervalued2026 world cup usa national team third place match key players possession football knockout prediction tactical review - ulpravda.ru
Aclarion says first patients enrolled at two additional CLARITY trial sites - TipRanks
Aclarion announces first patient enrollments at two additional Clarity trial sites - MarketScreener
Aclarion Advances Patient Enrollment in CLARITY Trial with Northwestern Medicine and Scripps Health Participation - Quiver Quantitative
AI spine scan study expands as hospitals test new back pain surgery guide - Stock Titan
Aclarion announces expansion plans with RadNet affiliates in NY, NJ - MSN
Aclarion (ACON) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Aclarion announces revised reverse stock split details - MSN
Aclarion (NASDAQ:ACON) Rating Increased to Hold at Wall Street Zen - Defense World
Aclarion, Inc. (NASDAQ:ACON) Sees Large Increase in Short Interest - Defense World
Aclarion announces publication of Nociscan article in pain issue of IJSS - MSN
What margin trends mean for Aclarion Inc. stock2025 Risk Factors & High Conviction Buy Zone Picks - Улправда
Is Aclarion Inc. stock a smart buy before Fed meeting2025 Fundamental Recap & Reliable Breakout Forecasts - Улправда
Is Aclarion Stock Built to Withstand a Pullback? - Trefis
Trading Action: Why Aclarion Inc. stock appeals to dividend seekersMarket Risk Report & Daily Growth Stock Investment Tips - Улправда
Is Aclarion Inc. stock cheap at current valuationPortfolio Value Summary & Growth-Oriented Investment Plans - Улправда
Retail Trends: Why Aclarion Inc. stock is seen as undervaluedShare Buyback & Community Consensus Picks - Улправда
Can Aclarion Inc. stock hit record highs again2025 Support & Resistance & Weekly Top Stock Performers List - Улправда
How Aclarion Inc. Equity Warrant stock benefits from global expansionGap Up & Long-Term Safe Investment Plans - Улправда
Will Aclarion Inc. Equity Warrant stock gain from strong economyEarnings Recap Summary & Community Trade Idea Sharing Platform - Улправда
Fund Flows: What margin trends mean for Aclarion Inc. stockMarket Performance Summary & Weekly Consistent Profit Watchlists - Улправда
Sell Signal: What margin trends mean for Aclarion Inc. stock2025 Trading Volume Trends & Weekly Hot Stock Watchlists - Улправда
Growth Value: What makes Aclarion Inc. (IT20) stock appealing to growth investorsWeekly Trade Review & Technical Analysis for Trade Confirmation - Улправда
Aclarion Earnings Notes - Trefis
Nasdaq Moves: Will ATLCP stock continue upward momentumWeekly Stock Summary & Daily Risk Controlled Trade Plans - moha.gov.vn
Ramsay Health Care (OTCMKTS:RMYHY) vs. Aclarion (NASDAQ:ACON) Financial Review - Defense World
What drives Aclarion Inc stock priceReal Estate Investment Trusts & These 3 Stocks Could Change Your Portfolio - earlytimes.in
Aclarion shares move higher after Nociscan highlighted in spine surgery journal - MSN
Aclarion (ACON) Price Target Increased by 15.00% to 23.46 - Nasdaq
Finanzdaten der Aclarion Inc-Aktie (ACON)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.93%
4.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):